Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × MEK inhibitor I × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Blood Specimen Collection 76 Surveys and Questionnaires 74 Surgical Procedures, Operative 39 Drug Therapy 27 Radiotherapy 24 Biopsy 21 Amplified Fragment Length Polymorphism Analysis 21 Immunohistochemistry 19 Gene Expression Profiling 19 Bevacizumab 19 Neoadjuvant Therapy 18 pembrolizumab 15 Ultrasonography 15 Nivolumab 15 Liquid Biopsy 15 Data Collection 15 Positron Emission Tomography Computed Tomography 14 Magnetic Resonance Spectroscopy 14 Capecitabine 14 Radiosurgery 13 Immunotherapy 13 Watchful Waiting 12 Oxaliplatin 12 Observation 12 Microarray Analysis 12 Magnetic Resonance Imaging 12 Interviews as Topic 12 Trastuzumab 11 Polymerase Chain Reaction 11 Paclitaxel 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05080361 2021-10-15

BRAFREC

University Hospital, Caen

16,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡